In our analysis of mRNA expression in n = 397 breast cancer samples, we found that 68% overexpress the RRAS2 gene compared to the mean of non-tumoral breast tissue samples, with a mean of 18.6 and a median of 2.1. The gene discussed is RRAS2; the disease is breast carcinoma.